Close
The UCL delegation attends the launch of the 'Centre for the Technologies of Gene and Cell Therapy'
5 September 2023
Following the earlier announcement that UCL has been named a key strategic partner in the new €30m EU-funded 'Centre for the Technologies of Gene and Cell Therapy' (CTGCT), the kick-off ceremony took place on 5 September in Slovenia.
Dr Jane Kinghorn, Director of the Translational Research Office, led a UCL delegation to join representatives from the European Commission, the Ministry of Health, and the Ministry of Higher Education, Science, and Innovation, and other project partners in attending the ceremony at the National Institute of Chemistry of Slovenia, followed by a productive internal kick-off meeting. During the meeting, key stakeholders reaffirmed the project's objectives and discussed various aspects of its implementation.
At the ceremony, Dr Jane Kinghorn delivered a short speech, expressing UCL’s commitment to sharing knowledge through this partnership project in support of the next generation of scientists in Slovenia and across Europe.
UCL scientists will act as a trusted experienced partner to the Centre, to support the transfer of knowledge of translation of Advanced Therapies (ATMPs) through to the clinical and commercial setting. This project may also facilitate cross-partner scientific collaborations to address current challenges and hurdles in progressing novel ATMP therapies in oncology and rare genetic diseases.
Look out for more announcements through the TRO describing opportunities for UCL researchers to become involved.
The UCL delegation:
- Dr Jane Kinghorn, Director of the Translational Research Office (TRO)
- Dr Pamela Tranter, Head of Translational Research Group, TRO
- Prof Simon Waddington, EGA Institute for Women’s Health
- Prof Giampietro Schiavo, Queen Square Institute of Neurology
- Mr Martin Scott, Head of European Innovation Management, The European Research & Innovation Office (ERIO)
Image 1: Dr Jane Kinghorn, Director of the Translational Research Office at UCL, speaking at the kick-off ceremony of the 'Centre for the Technologies of Gene and Cell Therapy'
Image 2:
Dr Jane Kinghorn (front row, second from right), Dr Pamela Tranter (front row, second from left), Prof Giampietro Schiavo (back row, first from right) and Mr Martin Scott (back row, second from left) meet with representatives of the project partners.
Image 3:
The Centre for the Technologies of Gene and Cell Therapy (CTGCT), established by the National Institute of Chemistry, officially started its work following the kick-off ceremony on 5 September 2023.
Image 4:
The UCL Delegation arrives in Slovenia to participate in the kick-off ceremony of the 'Centre for the Technologies of Gene and Cell Therapy' and the kick-off meeting.
Read more:
- Official launch of the Centre for the Technologies of Gene and Cell Therapy
- UCL named key strategic partner in EU’s new ‘Centre for the Technologies of Gene and Cell Therapy’
Interested to stay informed of upcoming news, events and funding calls?
- Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations
- Follow us on social media (LinkedIn, Twitter) and stay tuned to our news and updates.
TRO has created an online, internal portal (UCL sign-in required) to showcase the breadth of biomedical expertise at UCL and our partner hospitals, aiming to facilitate multidisciplinary collaborations and capabilities mapping.
- Input your profile to get your capabilities visible across UCL experts and potentially external partners facilitated by TRO, leading to collaboration and funding opportunities.